Medwise

At a glance

Pricing

Freemium + Pro.

HIPAA

Not disclosed

SOC 2

Not disclosed

EHRs

—

Founded

—

HQ

UK

Bottom line

UK-focused clinical Q&A with evidence retrieval.

Free tier available.

Overview

Pricing

What it costs

Free tier only; no paid plans publicly disclosed.

Source: vendor pricing page. Verified May 23, 2026.

Peer-reviewed coverage

What the literature says

2 peer-reviewed studies indexed on PubMed evaluate Medwise in clinical contexts. The most relevant are shown below, ranked by editorial relevance score combining title match, study design, recency, and journal tier.

Assessing the Impact of an Advanced Clinical Decision Support System on Medication Safety and Hospital Readmissions in an Innovative Transitional Care Model: A Pilot Study.

Bingham JM, Baugham L, Hilaneh A, et al.· J Clin Med· 2022

(1) Background: Adverse drug events and inappropriate use of medications lead to hospitalizations, medication-related morbidity, and mortality. This study examined whether a novel medication risk prediction tool, the MedWise Risk Score™, was associated with medication safety-related problem (MRP) identification and whether integration into an existing innovative transitions of care (TOC) service could decrease readmissions. (2) Methods: This retrospective comparator group study assessed patients discharged from a hospital in southern Arizona between January and December 2020. Participa…

Feasibility and Acceptability of a Pharmacogenomic Decision Support System in Palliative Care.

Bull JH, Bice T, Satterwhite WJ, et al.· J Palliat Med· 2022

Pharmacogenomic analysis may improve the efficacy or safety of the drugs used in palliative care. Decision support systems may promote clinical integration of this information.To determine the feasibility and acceptability of a pharmacist-directed pharmacogenomic decision support system in the care of patients with advanced illness and explore the drug-gene and drug-drug interactions that occur in this population.Physicians or nurse practitioners from two U.S. hospice agencies identified opioid-treated patients receiving multiple other drugs. Buccal samples and clinical data were obtained fro…

See all on PubMed